结节病复发风险因素:单中心回顾性聚类分析
该单中心回顾性聚类分析纳入160例结节病患者,采用K-means聚类识别复发风险亚组。结果显示三个不同聚类,吸烟(OR 2.3)、肥胖(OR 1.9)和长期使用激素超过12个月(OR 2.5)为复发的独立预测因素,提示需个体化管理。
要点
- 聚类分析识别出三个结节病复发风险亚组,特征各异。
- 吸烟、肥胖和激素使用超过12个月是复发的独立预测因素。
- 女性更多肺外受累,男性肺纤维化风险更高,但性别非显著预测因素。
核心结论
- 不同结节病表型影响复发风险,强调个体化管理的必要性。
研究设计与样本
- 单中心回顾性聚类分析,纳入160例结节病患者,采用K-means聚类,通过轮廓系数和肘部法确定最佳聚类数。
主要发现
- 聚类1(n=110)以Scadding I-II期为主,复发率低,激素反应好,长期并发症少。
- 聚类0(n=30)吸烟者更多,疾病晚期(Scadding III-IV),尽管治疗复发率高(p=0.003)。
- 聚类2(n=20)为肥胖伴全身症状(疲劳、呼吸困难)患者,复发率高,尤其在女性中(p=0.02)。
- 多因素分析证实吸烟(OR 2.3,p=0.002)、肥胖(OR 1.9,p=0.01)和长期激素使用超过12个月(OR 2.5,p=0.004)为复发的独立预测因素。
- 女性更多肺外受累,男性肺纤维化风险更高,但性别本身非显著预测因素(p=0.08)。
临床怎么用
- 聚类1患者可能以最小治疗实现缓解,聚类0和2需针对吸烟、肥胖和晚期疾病进行干预。
- 靶向干预包括戒烟、体重管理和早期激素节约治疗,可能改善长期结局并减少疾病负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Sarcoidosis is a systemic granulomatous disease with an unpredictable course. While corticosteroids are the mainstay of treatment, recurrence is common and influenced by clinical, demographic and therapeutic factors. However, an integrated approach to patient stratification remains underdeveloped. Research question What are the key clinical, demographic and therapeutic factors influencing sarcoidosis recurrence, and how can an integrated risk stratification model improve disease management? Methods We conducted a clustering analysis on 160 sarcoidosis patients to identify recurrence risk subgroups. Key variables included age, sex, body mass index, smoking history, Scadding stage, corticosteroid and immunosuppressant use, therapy duration and recurrence. K-means clustering was employed, with the optimal number of clusters determined using silhouette and elbow methods. Results Three distinct clusters emerged: Cluster 1 (n=110): predominantly Scadding stage I–II, low recurrence, favourable steroid response, minimal long-term complications. Cluster 0 (n=30): more smokers, advanced disease (Scadding III–IV), high recurrence despite treatment (p=0.003). Cluster 2 (n=20): patients with obesity with systemic symptoms (fatigue, dyspnoea), high recurrence, particularly in women (p=0.02). Multivariate analysis confirmed smoking (OR 2.3, p=0.002), obesity (OR 1.9, p=0.01) and prolonged steroid use (>12 months, OR 2.5, p=0.004) as independent predictors of recurrence. Sex differences were observed, with women showing more extrapulmonary involvement and men a higher risk of pulmonary fibrosis, though sex alone was not a significant predictor (p=0.08). Interpretation Distinct sarcoidosis phenotypes influence recurrence risk, underscoring the need for personalised management. While Cluster 1 may achieve remission with minimal therapy, Clusters 0 and 2 highlight smoking, obesity and advanced disease as recurrence drivers. Targeted interventions, including smoking cessation, weight management and early steroid-sparing therapy, could improve long-term outcomes and reduce disease burden.
引用
- BMJ Open Respiratory Research:Sarcoidosis relapse risk factors: a single-centre retrospective cluster analysis
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。